4D Molecular Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1.28 |
4.30 |
3.57 |
0.52 |
22.60 |
106.53 |
| Przychód Δ r/r |
0.00% |
234.59% |
-16.88% |
-85.42% |
4237.81% |
371.39% |
| Przychód (min) |
0.03 |
0.97 |
0.80 |
0.12 |
5.09 |
23.99 |
| Przychód (max) |
4.16 |
8.18 |
6.80 |
0.99 |
43.01 |
202.75 |
| EBITDA (średnia) |
-1.28 |
-4.30 |
-3.57 |
-0.52 |
-22.60 |
-106.53 |
| EBIT (średnia) |
-1.28 |
-4.30 |
-3.57 |
-0.52 |
-22.60 |
-106.53 |
| EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
| Zysk netto (średni) |
-154.44 |
-192.73 |
-221.88 |
-216.25 |
-236.81 |
-237.08 |
| Zysk netto % |
-12020.60% |
-4483.28% |
-6209.37% |
-41506.33% |
-1047.85% |
-222.54% |
| EPS (średnia) |
-2.91 |
-3.57 |
-3.83 |
-4.11 |
-4.39 |
-4.39 |
| Liczba analityków (Przychody) |
8 |
6 |
6 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
7 |
8 |
7 |
2 |
1 |
1 |
| symbol |
FDMT |
FDMT |
FDMT |
FDMT |
FDMT |
FDMT |